HIV News and Research

RSS

Researchers genetically modify a plant to halt reproduction of HIV related virus

In a study that could lead to new ways to prevent infection by human immunodeficiency virus (HIV) and similar organisms, Purdue University researchers have been able to genetically modify a plant to halt reproduction of a related virus.

31 Jul 2007

Chinese authorities ban AIDS conference

An AIDS conference planned to take place in China in August has been banned by government authorities.

30 Jul 2007

New target for drugs to fight the HIV/AIDS virus

Researchers from Rome, Italy, describe a finding in the August 2007 print issue of The FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection.

27 Jul 2007

Tonsil epithelial factors may influence oropharyngeal HIV transmission

Current research demonstrates that the tonsils may possess the necessary factors to act as a transmission site for the spread of HIV.

27 Jul 2007

Long-term herpes treatment may reduce HIV infectivity

Long-term anti-herpes treatment of women infected with both HIV and HSV2, the virus that causes genital herpes, may reduce the proportion of women with detectable HIV virus in their genital secretions according to the results of a trial in Tanzania presented the International AIDS Society Conference in Sydney.

26 Jul 2007

New findings on gene-transcription machinery

For some time, scientists have been tracking down the sequence of biochemical steps required to attract and assemble at the head end of a gene the molecular machinery needed to transcribe that gene to put to work the information it encodes.

26 Jul 2007

GPs antibiotic prescribing practices are still contributing to resistance

GPs are still prescribing antibiotics for up to 80% of cases of sore throat, otitis media, upper respiratory tract infections, and sinusitis, despite the fact that official guidance warns against this practice, according to an analysis of the world's largest primary care database of consultations and prescriptions, published this week in a supplement to the Journal of Antimicrobial Chemotherapy.

26 Jul 2007

Discovery of key HIV protein which makes cell membranes bend more easily

Carnegie Mellon University scientists have made an important discovery that aids the understanding of why HIV enters immune cells with ease.

26 Jul 2007

Children with HIV early antiretroviral therapy study

Hundreds of thousands of babies around the world are born each year with HIV--more than half a million in 2006 alone.

26 Jul 2007

Portmanteau inhibitors offer new way to tackle HIV

Researchers at the University of Minnesota's Center for Drug Design have developed a new method to combat HIV/AIDS, potentially replacing the traditional cocktail drug approach.

24 Jul 2007

New studies emphasize need for influenza and measles vaccinations in HIV-infected patients

Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals.

24 Jul 2007

Male circumcision reduces HIV risk by as much as 60%

Three clinical trials in Africa found that adult male circumcision reduced the risk of men acquiring HIV infection from heterosexual sex by 51-60%.

24 Jul 2007

U.S. anti-prostitution stance is not effective at helping to control the global HIV epidemic

In order to receive US funding for HIV prevention or control projects, recipient organizations must take a pledge that explicitly condemns prostitution.

24 Jul 2007

The good news and the bad news on AIDS

In an address by Dr. Anthony Fauci, George Bush's top adviser on HIV/AIDS, delegates were told the world is losing the battle against the virus and though progress had been made, more people were being infected with HIV than were being treated.

23 Jul 2007

Experts say world on the brink of beating AIDS

Leading AIDS experts speaking at an international conference in Sydney, Australia say the world is on the brink of beating the deadly virus.

23 Jul 2007

Koronis Pharmaceuticals issued U.S. patent for KP-1461 therapeutic in development for treatment of HIV

Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 -- the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.

23 Jul 2007

Urgent needs of HIV-positive women discussed

Women Living Positive, a roundtable discussion at the IAS congress in Sydney, featured the perspectives of an international panel, including experts in HIV research and medicine, an HIV-positive woman and a member of Australia's National Association of People Living with HIV/AIDS (NAPWA), on the progress that has been made, and what remains to be done to address the needs of HIV-positive women.

23 Jul 2007

Patients' perspectives on living with HIV

Recent launches of new protease inhibitors and the anticipated availability of new antiretroviral drug classes have increased the therapeutic options available to treatment-experienced HIV-positive patients, and made achieving an undetectable viral load a realistic goal for this patient population.

23 Jul 2007

Sexually transmitted diseases flourishing in the UK

According to the latest research sexually transmitted infections continue to flourish in the UK and have in fact risen for the 10th successive year.

22 Jul 2007

Long term antiretroviral therapy may restore CD4 cell counts in HIV positive patients

HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative individuals, if they remain on the therapy for long enough and their HIV viral load load is suppressed to below 50 copies per ml.

20 Jul 2007